Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2015; 61(5): 90-98


O. Linnik, T. Drevytska, O. Gonchar, S. Chornyy, O. Kovalyov, I. Mankovska

    O.O. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv


It was studied the effect of doxorubicin on the HIF system and the pro–antioxidant balance of neonatal cardiomyocytes as well as the possibility of the oxidative stress correcting using curcumin. It has been revealed that the expression of mRNA HIF-1α using doxorubicin at a dose of 0,5 µM was 2.9 ± 0.8 cu, so it decreased by 20% compared to control - 3.6 ± 0.7 cu (Р<0.05). The level of expression of the HIF target gene PDK-1 also significantly decreased (4 times). During the incubation with doxorubicin, the number of live cells decreased by 50,4% relative to control. And after using doxorubicin and curcumin together, the percentage of dead cells decreased by 7,7 compared to doxorubicin only. Doxorubicin intoxication led to a significant increase in the secondary products of lipid peroxidation (TBARS) in cardiomyocytes by 3.6 times and hydrogen peroxide by 64%. Prolonged incubation with doxorubicin reduced the enzymatic activity of Mn-SOD by 32%, while catalase activity increased by 72% compared to control. Adding of curcumin to the cardiomyocyte cell culture contributed to increasing of the Mn-SOD activity by 14%, catalase – by 23%. The level of TBARS increased by 1,4 times compared with the control, and the level of Н2О2 increased by 20%. The joint use of doxorubicin and curcumin resulted in a significant reduction of free radical oxidation unlike effect of doxorubicin per se. Specifically, there was lessening of TBARS and Н2О2 (at 56.7 and 18.4% respectively), while decreasing of the catalase hyperactivation (19%) and rising of the Mn-SOD activity (35%).

Keywords: oxidative stress, cardiomyocytes, HIF-1α, doxorubicin, curcumin.


  1. Cadenas E, Davis KJ. Mitochondrial free radical generation, oxidative stress, and ageing. Free Rad. Biol. Med. 2000; 29: 222–30.
  3. Raha S, Robinson BH. Mitochondria, oxygen free radicals and apoptosis. Semin. Med. Genet. 2001; 106:62-70.
  5. Goda N, Kanai M. Hypoxia-inducible factors and their roles in energy metabolism. Int J Hematol. 2012; 95:457–63. CrossRef PubMed
  7. Weidemann A, Johnson RS. Biology of HIF-1a. Review Cell Death and Differ. 2008; 15: 621–27 CrossRef PubMed
  9. Lee K, Qian D, Rey S, Wei H, Liu J, Semenza G. Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells. Proc. Nat. Acad. Sci. USA. 2009; 106(7):2353-8. CrossRef PubMed PubMedCentral
  11. Chen TH, Yang YC, Wang JC, Wang JJ. Curcumin treatment protects against renal ischemia and reperfusion injury-induced cardiac dysfunction and myocardial injury. Transplant Proc. 2013; 45(10):3546-9. CrossRef PubMed
  13. Aggarwal S, Ichikawa H, TakadaY, Sandur SK, Shishodia S, AggarwalB. Curcumin (diferuloymethane) down regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of I kappa B alpha kinase and Akt activation . Mol. Pharmacol. 2006; 69(1):195-206.
  15. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kB proinflammatory cytokines production and oxidative stress. Biochem. Biophys. Acta. 2007; 1770:989-96.
  17. Swamy AV, Gulliaya S, Thippeswamy A, et al. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 2012; 44: 73–7. CrossRef PubMed PubMedCentral
  19. Mohamad RH, El-Bastawesy AM, Zekry ZK, et al. The role of Curcuma longa against doxorubicin (adriamycin) - induced toxicity in rats. J Med Food 2009; 12: 394–402. CrossRef PubMed
  21. Stalnaya ID, Garishvili TG. Method of determination of malondialdehyde using thiobarbituric acid. Modern methods in biochemistry. 1977; 66-8. [Russian].
  23. Huwiler M, Kohler H. Pseudo-catalytic degradation of hydrogen peroxide in the lactoperoxidase/H2O2/iodide system. Eur. J. Biochem. 1984; 141: 69-74.
  25. Misra H, Fridovich I. The role of superoxide anion in the autoxidation of Epinephrine and a simple assay superoxide dismutase. J. Biol. Chem. 1972; 247(10): 3170-5.
  27. Koroljuk M, Ivanov L, Mayorov I, Tokarev V.Method for determination of catalase activity. Lab. Business. 1988; 1:16-9 [Russian].
  29. Linnik O, Drevytska T, Chornii S, Dosenko V, Mankovska I. Effect of doxorubicin on the culture of isolated neonatal rats cardiomyocytes. Bulletin VNMU. 2014; 2(18):383-7. [Ukrainian].
  31. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF- 1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006; 3:177–85. CrossRef PubMed
  33. RapisardaA, Melillo G. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nature. Reviews. Clinical Oncology. 2012; 9:378-90.
  35. Tanaka T, Yamaguchi J, Shoji K, Nangaku M. Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host. J. Biol. Chem. 2012; 287(42):34866-82.
  37. Hyunsung Choi, Yang-Sook Chun, Seung-Won Kim, Myung-Suk Kim, and Jong-Wan Park. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol. 2006; 70:1664–71. CrossRef PubMed
  39. Menshchikova E, Zenkov N. Antioxidants and inhibitors of radical oxidation processes. Adv. Mod. Biol. 1993; 113 (4):442-53. [Russian].
  41. Sazontova T, Anchishkin N, Zhukov A. Role of reactive oxygen spcies and redox signaling in adapting to change of the oxygen content. Fiziol. Zh. 2008; 54 (2):18-32. [Russian].
  43. Wang J, Ma J, Giffard R. Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury. Free Radic.Biol.Med. 2005; 38(8):1112-8.
  45. Srivastav G and Mehta JL. Currying the heart: curcumin and cardioprotection. J Cardiovasc Pharmacol 2009; 14: 22–7. CrossRef PubMed
  47. Grisham M, McCord J. Chemistry and cytotoxicity ofreactive oxygen metabolites. In: Taylor A, Matalon S, Ward P, editors. Physiology of oxygen radicals. Bethesda: Am Physiol Soc; 1986. pp. 1–18.
  49. Appiah R, Commandeur JN, Vermeulen NP. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products.Toxicology.2007; 235:83–91. CrossRef PubMed
  51. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med. 2007; 43:568–80. CrossRef PubMed PubMedCentral
  53. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. Adv Exp Med Biol. 2007; 595:359–77. CrossRef PubMed
  55. Cremers NA, Lundvig DM, vanDalen SC, Schelbergen RF, vanLent PL, Szarek WA, Regan RF, Carels CE, Wagener FA. Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem sells. Int J MolSci. 2014; 8;15(10):17974-99.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.